Whole-genome sequencing enables complete characterization of genetic variation, but geographic clustering of rare alleles demands many diverse populations be studied. Here we describe the Genome of the Netherlands (GoNL) Project, in which we sequenced the whole genomes of 250 Dutch parent-offspring families and constructed a haplotype map of 20.4 million single-nucleotide variants and 1.2 million insertions and deletions. The intermediate coverage (~13×) and trio design enabled extensive characterization of structural variation, including midsize events (30-500 bp) previously poorly catalogued and de novo mutations. We demonstrate that the quality of the haplotypes boosts imputation accuracy in independent samples, especially for lower frequency alleles. Population genetic analyses demonstrate fine-scale structure across the country and support multiple ancient migrations, consistent with historical changes in sea level and flooding. The GoNL Project illustrates how singlepopulation whole-genome sequencing can provide detailed characterization of genetic variation and may guide the design of future population studies. including characterization of structural variation, detection of de novo events, imputation and demographic inference.
A r t i c l e s
Specifically, we sampled 231 trios, 11 quartets with monozygotic twins and 8 quartets with dizygotic twins from 11 of the 12 Dutch provinces without ascertaining on the basis of phenotype or disease. By wholegenome sequencing these 250 families at ~13× coverage, our aim was to build a resource of 1,000 haploid genomes as representative of a small (41,543-km 2 ), densely populated (>17 million inhabitants) country in northwestern Europe (Supplementary Note).
Here we provide the first detailed analysis of the GoNL data after processing and quality control ( Supplementary Fig. 1 and Supplementary Note). To maximize sensitivity, we analyzed all samples jointly 18 and discovered 20.4 million biallelic SNVs, 1.2 million biallelic indels (<20 bp in length) and 27,500 larger deletions (>20 bp in length). Of the SNVs, 6.2 million are common (minor allele frequency (MAF) > 5%), 4.0 million are low frequency (MAF = 0.5-5%), and 10.2 million are rare (MAF < 0.5%). On the basis of coverage and mapping metrics, we estimate that 94.1% of the genome could be called reliably (the 'accessible' genome), within which 99.2% of SNVs with a frequency of 1% could be detected (Supplementary Table 1 and Supplementary Note). The identification of indels and large deletions was based on conservative consensus calls from several complementary methods (Supplementary Note). We used MVNcall for trio-aware phasing and linkage disequilibrium-based imputation 19 , starting from the genotype likelihoods of SNVs and indels, yielding a phased panel of 998 unique haplotypes. The non-reference genotype concordance for SNVs was 99.4% (compared to genotypes from Complete Genomics sequencing data in 20 overlapping samples) and 99.5% (compared to Illumina Immunochip genotypes collected for all samples). The average coverage of 13.3× coupled with the family-based design allowed us to construct a high-quality whole-genome data set for further analysis, Whole-genome sequence variation, population structure and demographic history of the Dutch population
The Genome of the Netherlands Consortium* Although the human genome reference sequence provides a common scaffold for the annotation of genes, regulatory elements and other functional units, it does not contain information about how individuals differ in their DNA sequences 1 . Initial efforts to map such variation across the human genome have successfully catalogued millions of common SNPs in various populations [2] [3] [4] [5] . Fueled by the commercial development of microarrays for efficient SNP genotyping, genome-wide association studies (GWAS) have provided a systematic approach to test genetic variants for a role in disease. Thus far, GWAS have reproducibly identified thousands of loci, providing insight into underlying pathways of disease, in some cases with translational and clinical impact 6, 7 . The importance of these discoveries notwithstanding, many questions remain about the allelic architecture of complex traits, especially with regard to the contributions of common versus rare variation [7] [8] [9] .
To elucidate the genetic basis of disease, comprehensive sequencingbased approaches are required to interrogate all types of genetic variation, including single-nucleotide variants (SNVs), structural variations and de novo events [10] [11] [12] . The characterization of rare variation poses a major challenge. Because rare alleles have emerged, on average, relatively recently 13 , they show greater geographic clustering 14 than common variants 15 . It is therefore imperative to study large samples across multiple populations, even within continental groups, to build a relatively complete catalog of rare variation in the human genome.
We initiated the Genome of the Netherlands (GoNL) Project to characterize DNA sequence variation for SNVs, short insertions and deletions (indels) and larger deletions in 769 individuals of Dutch ancestry selected from 5 biobanks under the auspices of the Dutch hub of the Biobanking and Biomolecular Research Infrastructure (BBMRI-NL) 16, 17 .
Functional variation
Predicting the biological consequences of variants within a single genome is an ongoing challenge with important implications for using sequencing in a clinical setting. To characterize the burden of loss-of-function variants in detail, we classified all such variants in GoNL 21 (Supplementary Note). Among rare variants, we observed an excess of nonsense variants and frameshift indels, consistent with a model in which such functional variants are subject to purifying selection ( Supplementary Fig. 2 ) 22, 23 . We counted 66 larger lossof-function deletions (removing the first exon of a gene or more than half of its coding sequence) 21 , which showed a relative depletion in numbers when compared to all deletions (P = 0.005 for deletions of 20-100 bp; P = 2.6 × 10 −9 for deletions of >100 bp). This effect was amplified when considering only genes listed in the Online Mendelian Inheritance in Man (OMIM) compendium (P = 2.4 × 10 −27 ), illustrating strong selection against large structural changes in key genes.
The overall patterns and per-individual distributions of lossof-function SNVs (variants introducing premature stop codons or variants interrupting splice sites) and missense variants were consistent with those found in the 1000 Genomes Project ( Table 1 and Supplementary Fig. 3 ). On average, an individual carried 60 loss-of-function SNVs, 69 loss-of-function indels and 15 loss-of-function large deletions. The bulk of these mutations for each individual were common, suggesting that these variants are not subject to strong selective pressure and, although they are protein-truncating mutations, are likely phenotypically benign. This observation emphasizes the need for caution in assigning pathogenicity to variants purely on the basis of their predicted impact on protein structure.
In contrast, when considering rare loss-of-function variants, which are more likely to be pathogenic, we found that the average individual in GoNL carried four nonsense variants, two variants interrupting a splice site and two frameshift indels. Comparing these numbers to those for synonymous variants (providing a baseline expectation under neutrality), we estimate that each individual carried an excess of 4-5 rare lossof-function SNVs sufficiently deleterious that they would never reach high frequency in the population (Supplementary Note).
We also investigated the number of rare loss-of-function compound heterozygous events for SNVs, short indels and large deletions. Across all samples, we observed 3 such events mapping to 3 genes in 3 individuals (average of 0.01 events per individual). Given the rarity of such variants, the phenotypic impact of compound heterozygosity for rare loss-of-function mutations should be considered explicitly in disease studies.
Whereas compound heterozygosity for rare loss-of-function variants was sparse, we expected compound heterozygosity for common loss-of-function variants to be more prevalent, as these variants are less likely to be deleterious. Indeed, we found that the average number of common loss-of-function compound heterozygous variants per individual was 2.89 (range of 0-7). Interestingly, although there were 1,917 common loss-of-function compound heterozygous events across all samples, they were confined to only 11 genes (Supplementary Table 3 ). All but one of these genes have extreme residual variation intolerance scores 24 (RVIS; all but 1 gene above the 84th percentile across 16,956 genes), which is unlikely to occur by chance (P = 1.41 × 10 −5 ; Our detection strategy employed multiple approaches and provided a substantial boost in the identification of novel structural variants in the midsize range (30-500 bp). Peaks corresponding to long interspersed elements (LINEs), short interspersed elements (SINEs) and microsatellite instability (MSI) are highlighted. The total number of variants called in GoNL is shown in orange, whereas SNVs found in dbSNP (Build 137) and short indels and large deletions found in 1000 Genomes Project Phase 1 data are shown in blue. For large deletions (>20 bp), we required at least 80% reciprocal overlap between variants for them to be considered similar.
A r t i c l e s npg A r t i c l e s Supplementary Fig. 4 ) and suggests that these genes are more tolerant of disruptive mutations. Because databases of disease-relevant mutation are often employed to identify potential variants of interest, we annotated variants in GoNL that were listed as disease causing (DM) in the Human Gene Mutation Database (HGMD) 25 . We observed that a sample carried, on average, 20 DM variants (range of 9-33) ( Table 1) . Because all samples were derived from population-based cohorts, the impact of these alleles is unclear. One possibility is that the presence of modifier alleles induces incomplete penetrance or variable expressivity of DM variants, depending on the carrier's genetic background 26 . An alternative explanation is that HGMD contains a considerable number of false positive disease-causing mutations 27 . Of the 1,093 DM mutations occurring in GoNL, 32% had a frequency of >1%, higher than the prevalence of many of the diseases described in HGMD. Given the inheritance patterns of the diseases conferred by these variants, many individuals in GoNL should have been affected by diseases with profound physical or even lethal manifestations ( Table 2 and Supplementary Table 4 ). In fact, one of these variants (chr. 14: 94,847,262; a variant for α1 antitrypsin deficiency) was recently implicated as a pathogenic incidental finding in a set of 1,000 exomes 28 . The prevalence of α1 antitrypsin deficiency (MIM 613490), an autosomal recessive disease, is estimated to be 0.02-0.06%, yet two unrelated GoNL individuals were homozygous carriers of this variant (prevalence = 0.4%, ~10× higher than the disease prevalence). Further, the typical age of onset of α1 antitrypsin deficiency is 20-50 years, whereas the two homozygous carriers in GoNL were ages 60 and 63 years at ascertainment. These results highlight the potential pitfalls of employing such databases in disease studies and the challenge of interpreting personal genomes.
De novo mutations
A distinct advantage of the family-based study design is the ability to call de novo events in genomic regions with sufficient coverage in a trio. To this end, we developed the PhaseByTransmission (PBT) module in the Genome Analysis Toolkit (GATK) 29 (Fig. 2a) . This analysis illustrates how joint assessment of raw trio data and sequencing context can greatly boost prediction accuracy. We applied the classifier to our initial candidates and identified 11,020 high-confidence de novo mutations (18-74 per offspring) for downstream analyses. Owing to fluctuations in regional coverage, we expect a substantial fraction of genuine de novo mutations to have been missed. We also note that early embryonic somatic mutations would be indistinguishable from germline mutations.
We observed a significant positive correlation (r 2 = 0.47, P < 2.2 × 10 −16 ) between father's age at conception and number of de novo mutations in the offspring (Fig. 2b) , providing a third, independent estimate based on a larger sample size 30, 31 . Assuming mutations are Poisson distributed among samples and adjusting for coverage, we estimated that each additional year of father's age caused a 2.5% increase in the mean number of de novo mutations in the offspring. Although parents' ages were highly correlated (r 2 = 0.66), comparing models based on father's and mother's age at conception suggested that the age-related increase in the frequency of de novo mutations was a predominantly paternal effect (Supplementary Note). Interpolating from the paternal model, we expected, on average, 75.4% of the de novo mutations in the GoNL offspring to originate from the father (assuming a linear increase in the number of de novo mutations from puberty). Using read-pair information, we were able to assign parental origin to 2,613 de novo mutations, and we found that, indeed, 76.0% were paternal. When considering only mutations for which parental origin could be determined, the correlation with father's age remained significant (r 2 = 0.11, P = 2.0 × 10 −6 ; Supplementary Fig. 5 ), but the correlation was not significant for mother's age (P = 0.94), highlighting the relative impact of paternal and maternal mutations.
Within a single family, we attempted to identify de novo indels and large deletions. Using strict filtering criteria for mendelian violations followed by PCR-based Sanger sequencing (Supplementary Note), we confirmed six intergenic de novo indels (1-2 bp) and a large 113-kb de novo deletion located in an intron of the SUMF1 gene (which seems unlikely to have substantial impact on gene function). These results show that our predictions of indels and structural changes are a valuable source for both commonly segregating alleles A r t i c l e s and de novo events. Further work is needed to assess the frequency of such de novo events in the general population.
Imputation
One of the goals of the GoNL Project was to provide a community resource for downstream imputation into GWAS samples. To evaluate the performance of the GoNL panel, we used independent Complete Genomics sequence data collected for 81 individuals of Dutch ancestry (the NTL data set). In these NTL samples, we masked all genotypes at SNVs not present on the Illumina Human-1M array, imputed these masked SNVs from the remaining SNVs and then compared the imputed and known genotypes (Supplementary Note). The aggregate mean r 2 value was 0.99 for common SNVs, 0.86 for low-frequency SNVs and 0.63 for rare SNVs, indicating good overall imputation quality (Fig. 3) . We repeated this evaluation on the basis of the SNV content of other microarrays and obtained similar imputation performance for common SNVs, but we observed notable differences in imputation quality for lower frequency alleles ( Supplementary  Fig. 6 ). To directly measure the impact of trio-based phasing, we constructed a panel using data from the unrelated parents alone and Figure 2 De novo mutation detection. (a) Receiver operating characteristics (ROC) curve to predict de novo mutations using PhaseByTransmission only (purple line; 2,199 sites) or using PhaseByTransmission followed by random forests classification trained on 70% of the validation data (green dot; evaluation subset only, 657 sites). The random forests classifier had an estimated 84.5% sensitivity and 94.6% specificity. (b) The number of de novo mutations in each of the 258 independent offspring is plotted (in blue) as a function of paternal age at conception. Linear regression of mutational load on paternal age is significant (Pearson's correlation = 0.47, P < 2.2 × 10 −16 ), with the least-squares fit plotted in orange.
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A r t i c l e s reevaluated imputation quality in the NTL samples. The imputation accuracy dropped to a mean r 2 value of 0.47 for rare variants (0.85 and 0.98 for low-frequency and common SNVs, respectively), indicating that trio-based phasing contributed substantially to the imputation quality of rare variants. In comparison to imputation using 1000 Genomes Project data as the reference panel, we observed better imputation accuracy with the GoNL panel for SNVs with a frequency of up to 10%, despite the larger sample size of the 1000 Genomes Project (Fig. 3) . To investigate the basis for the improved imputation accuracy with the GoNL panel, we constructed 3 reference panels using the 1000 Genomes Project CEU (Northern and Western Europeans from Utah) and TSI (Tuscans from Italy) panels and the GoNL panel, all with 85 individuals. Using each of these reference panels, we imputed into independent CEU, TSI and NTL samples with Complete Genomics data (Supplementary Note).
Of the three panels, GoNL gave the highest imputation accuracy (especially for rare variants), not only for the NTL samples but also for the CEU samples, indicating that the improved performance of the GoNL panel was not simply due to shared ancestry of the GoNL and NTL samples (Supplementary Fig. 7) . Differentiation between northern and southern European populations might explain why the 1000 Genomes Project CEU panel and the GoNL panel showed roughly equivalent performance for the TSI panel (with performance certainly worse than when the 1000 Genomes Project TSI panel was used as the reference). Overall, these results suggest that the GoNL design enabled accurate reconstruction of long-range haplotypes with marked improvement in imputation of rare alleles.
To assess the potential value of larger reference panels, we combined the 1000 Genomes Project and GoNL panels with IMPUTE2 (ref. 32), and we evaluated imputation accuracy in the NTL samples. Here we obtained an additional gain in accuracy over the GoNL panel alone, achieving a mean r 2 value of 0.70 for rare SNVs and 0.88 for low-frequency SNVs (Fig. 3) . Increasing the sample size of the reference panel will likely continue to improve imputation performance (especially for lower frequency alleles), motivating a community-wide effort to create a unified reference panel across diverse populations.
Population structure and demographic inference
Although it is well understood that extensive migration and gene flow occurred among European populations [33] [34] [35] , we focused on creating a unified picture of Dutch demography in recent millennia. Because of unbiased ascertainment and the inclusion of rare variation, wholegenome sequence data can potentially offer greater resolution for demographic inference than SNP array data.
First, we explored global relationships, analyzing both common and rare variants to elucidate ancient and recent population differentiation. We calculated Hudson's F ST between the Dutch population and the 14 populations present in the 1000 Genomes Project, finding that F ST patterns were consistent with continental clustering in principal-component analysis (PCA) and with previous estimates (Supplementary Fig. 8 and Supplementary Table 5) 36 . To investigate more recent population connections, we focused on so-called f 2 variants, mutations appearing exactly twice (in two heterozygote carriers) in the joint data from GoNL and the 1000 Genomes Project (Supplementary Note). As was observed in the 1000 Genomes Project, within-population sharing accounted for the majority (50.8%) of all f 2 alleles (Supplementary Fig. 9 ), but f 2 sharing identified cross-population connections as well. For example, a Dutch sample sharing an f 2 variant with a non-Dutch individual was far more likely to share that variant with another individual from Europe (71.6%) or the Americas (21.0%; because of European admixture) than with an individual from Africa (6.2%) or East Asia (1.3%). These results underscore the high degree of geographic clustering of recent mutations. In analysis of mitochondrial DNA, the frequencies of the major haplogroups (H, 39.4%; U, 25.2%; J, 10.4%; T, 10.8%) and minor haplogroups were in agreement with previous observations in other European populations (Supplementary Note) 37 .
Within the Netherlands (Fig. 4a) , PCA showed subtle substructure along a north-south gradient ( Fig. 4b and Supplementary Note), consistent with previous findings 38, 39 . Because PCA cannot elucidate demography (particularly migration patterns) 40 , we also performed an independent analysis of identity-by-descent (IBD) sharing that identified subtle signals of migration (Supplementary Note) 41 . From the length distributions of the IBD segments 42 , we inferred demographic models and estimated the effective population sizes of the Dutch provinces at different time scales, reflecting historical changes in demography (Supplementary Note).
Analysis of IBD segments of 1-2 cM in length, corresponding to an estimated time to the most recent common ancestor of ~4,200 years, showed homogeneous effective population sizes across the 11 provinces, consistent with common genetic origins ( Supplementary  Fig. 10 ). Additionally, we observed a smooth south-to-north gradient of decreasing ancestral population size and increased homozygosity in the northern provinces (average within-province IBD sharing and latitude correlation, r = 0.923, P = 5 × 10 −5 ; Supplementary Figs. 10 and 11, and Supplementary Note). Traditionally, such observations have been explained by a serial founder effect characterized by migration from the south to the north 38 .
Interestingly, GoNL samples, regardless of place of birth, tended to share more IBD segments with other individuals from the north than with individuals from the same region. Although within-province IBD sharing was strong, excess sharing with individuals from the the northern provinces was evident (average between-province IBD sharing and average province latitude correlation, r = 0.934, P < 1 × 10 −5 ; Fig. 4c and Supplementary Table 6 ). This pattern indicates that a simple south-to-north serial founder model might not be sufficient to explain the observed IBD sharing ( Supplementary  Fig. 12 and Supplementary Note). Instead, different demographic 
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A r t i c l e s scenarios remain plausible, but all support a model of substantial regional migration. Assuming that ancient serial migrations toward the north of the country caused the observed gradient of increasing homozygosity, a possible explanation for these results is that additional migratory events out of the north took place after initial settlements. These subsequent migratory events are consistent with the dynamic nature of the Netherlands, particularly in the northern coastal regions, between 5000 BCE and 50 CE (Supplementary Fig. 13 ). A series of abandonments and resettlements were likely prompted by shifts in ocean level and flooding that changed once-habitable land into dunes and marshes or buried regions entirely underwater. We emphasize that other, more complex demographic models might yield similar patterns of IBD sharing; additional analyses are required to assess alternative scenarios. In recent centuries, the advent of water-defense technologies (beginning in the thirteenth century) increased land stability, allowing for other forces to influence demography. An analysis of f 2 variants identified non-random sharing within and across provinces. Although the proportion of within-province f 2 sharing comprised only 12% of all f 2 alleles, consistent with homogenous ancestry, this is significantly greater than expected under the null hypothesis of uniform allele sharing (P < 1 × 10 −200 ; Fig. 4d ). This geographic localization of rare variants is suggestive of limited migration in recent centuries, consistent with current demographic studies. Notably, the Noord-Brabant and Overijssel provinces showed significantly stronger within-province f 2 sharing than the other provinces (P = 1.2 × 10 −151 and P < 1 × 10 −200 , respectively), consistent with smaller effective population sizes in these two provinces inferred from sharing of long IBD segments (Fig. 4c, Supplementary Fig. 9 and Supplementary Table 6 ). Further, we found that within-region sharing in the northern and southern regions was substantially stronger when compared to such sharing in the central region (P < 1 × 10 −200 , both comparisons). Taken together, these results suggest increased migration in the central region (in comparison to the northern and southern regions), consistent with recent urbanization in the wealthier central provinces.
DISCUSSION
The results presented here reflect the enormous wealth of knowledge that can be gleaned from whole-genome sequencing data and illustrate how intermediate-coverage sequencing within a single country complements cosmopolitan, low-coverage efforts 20 . The observed proportion of novel variation (in particular, for structural variation) underlines the added value of in-depth population studies such as GoNL. Combining sequencing data sets within and across populations will not only maximize sensitivity and resolution for the discovery of all types of DNA variation but will also enable population genetic analyses that can shed more light on local and global shared ancestry.
In spite of the intermediate coverage in GoNL, we were able to reliably call de novo point mutations and confirm the relationship between paternal age at conception and mutation load in offspring. We showed that we could also identify larger de novo events; these calls will have to be validated empirically and their properties studied across the entire cohort. The methods we developed for the discovery of de novo mutations should be broadly applicable for studies of diseases in which de novo mutations are suspected to have a role 12 . De novo mutation represents an important class of DNA sequence variation that can further elucidate fundamental processes of mutagenesis 43 . Our results indicate that trio-based sequencing of large samples at intermediate coverage may be a costeffective way to ascertain genome-wide variation in mutation rates and establish a 'null expectation' for the general population against which mutations in cases can be compared. Similarly, populationbased sequencing efforts are instrumental in defining guidelines for investigating the causality of variants that may have functional and phenotypic impact 44 .
As long as the cost of genotyping continues to be competitive with whole-genome sequencing, imputation will remain important. The consolidation of available whole-genome data sets into a single cosmopolitan panel, including low-frequency, structural and other complex types of variation 45, 46 , should therefore be considered a top priority. Through more complete interrogation of genetic variation, studies of large, well-phenotyped samples will continue to increase Fig. 4 and Supplementary Table 7) . Limited phenotype data were available: age, sex, height, body mass index (BMI) and levels of total cholesterol, high-density lipoprotein (HDL)-cholesterol, low-density lipoprotein (LDL)-cholesterol and triglycerides (Supplementary Fig. 14) . All participants provided written informed consent, and each biobank was approved by their respective institutional review board (IRB).
Data generation and processing. Samples were sequenced on an Illumina HiSeq 2000 instrument (91-bp paired-end reads, 500-bp insert size), and reads were aligned on the UCSC human reference genome build 37 using BurrowsWheeler Aligner (BWA) 0.5.9-r16 (refs. 47, 48) . Samples were also genotyped on the Illumina Immunochip as well as on at least one other genotyping chip (Supplementary Table 8 ).
Single-nucleotide variant calling. SNV calling was performed on all samples jointly using GATK UnifiedGenotyper v1.6. Calls were filtered using GATK VariantQualityScoreRecalibration ( Supplementary Fig. 15 and Supplementary Note), and quality metrics were evaluated ( Supplementary  Fig. 16 , Supplementary Table 9 and Supplementary Note). We defined the accessible genome using the same methodology as the 1000 Genomes Project 20 ( Supplementary Fig. 17 and Supplementary Note). We assessed the robustness of our pipeline with respect to its stochastic components, its parameters and the version of the tools by reprocessing one trio under different conditions (Supplementary Tables 10 and 11 , and Supplementary Note).
Indels and structural variants. To create reliable indel and structural variant call sets, we used a combination of ten algorithms (GATK UnifiedGenotyper, Pindel 49 , 1-2-3SV (see URLs), Breakdancer 50 , DWAC (see URLs), CNVnator 51 , FACADE 52 , MATE-CLEVER 53 , GenomeSTRiP 54 and SOAPdenovo 55 ). These algorithms are based on six approaches: (i) gapped reads, (ii) split reads, (iii) read pairs, (iv) read depth, (v) combined approaches and (vi) de novo assembly (Supplementary Table 12 ). Each of the ten tools was run, and calls for each were filtered separately (Supplementary Note). Variants were divided into three groups according to their size (1-20 bp, 20-100 bp and >100 bp), and different merging and filtering criteria were applied to obtain the final set (Supplementary Note).
Mitochondrial DNA. Unmapped reads were remapped to an appended version of the revised Cambridge Reference Sequence (rCRS) 56, 57 . Consensus sequences were called using GATK and used for phylogenetic analyses. All sequences were assigned to haplogroups according to the human mitochondrial DNA phylogeny 58 . Analysis of molecular variance (AMOVA) based on provincial haplogroup frequencies was performed using Arlequin 59 v3.5.1.2 ( Supplementary Fig. 18 and Supplementary Note).
Validation of de novo variants.
A total of 1,133 de novo mutations in 54 families were assayed using 3 sequencing technologies (Supplementary Note). Variants called using Sanger sequencing were analyzed manually using Phred 60, 61 . MiSeq and IonTorrent data were aligned to the reference genome using the BWA and TMAP 62 aligners, respectively, and genotyped with the GATK UnifiedGenotyper. Putative de novo indels and structural variants in one trio were selected for validation. De novo indel candidates were sequenced using a MiSeq instrument, reads were aligned to the reference genome using BWA, and candidates were genotyped with the GATK HaplotypeCaller.
De novo structural variant candidates were sequenced with Sanger sequencing, and traces were analyzed by NCBI BLAST 63 .
Validation of polymorphisms.
We randomly selected 433 deletions and 407 insertions for validation in one family, considering novelty (compared to the 1000 Genomes Project), allele frequency (rare, <0.5%; low frequency, 0.5-5%; common, >5%) and size (short, ≤10 bp; long, >10 bp). Candidates were sequenced using a MiSeq instrument, and reads were aligned to the reference genome, with additional non-reference allele contigs for all candidates larger than (1-kb padding). Indels of <6 bp in length were genotyped using the GATK HaplotypeCaller, and larger indels were genotyped using read counts mapping to the reference and non-reference allele contigs (Supplementary Note).
A random set of 96 medium-length (20-to 100-bp) and 48 large (>100-bp) deletions was assayed in one sample by Sanger sequencing (Supplementary Table 2 and Supplementary Note). Sanger sequencing data were called using Phred 60, 61 and aligned to the reference genome with NCBI BLAST 63 . Mediumlength deletions were also sequenced on a MiSeq instrument, and reads were aligned to the reference genome with additional non-reference allele contigs. Genotyping was based on read counts mapping to the reference and non-reference allele contigs.
Variant annotation. We functionally annotated SNVs with the Variant Annotation Tool 64 (VAT) and SnpEff 65 (Supplementary Note), keeping only concordant annotations in coding regions and VAT annotations in noncoding regions (SnpEff provides annotations only for coding regions). Nonsynonymous SNVs were annotated with Polymorphism Phenotyping v2 (PolyPhen-2) 66 . SNVs in OMIM and 'disease-causing' SNVs in HGMD were annotated. SNVs were also annotated with Genomic Evolutionary Rate Profiling 67 (GERP) scores and ancestral and derived allele status. Indels were annotated using indelMapper in VAT with GENCODE v16 annotations (Supplementary Note). Structural variants were annotated on the basis of RefSeq 68 annotations, and loss-of-function annotations were defined using MacArthur et al. 21 (Supplementary Note). Overall and per-sample variant counts stratified by novelty and functional impact were computed for all variants ( Table 1, Supplementary Table 13 and Supplementary Note).
Loss-of-function analyses. We computed excess loss-of-function mutations per genome on the basis of the expected loss-of-function/synonymous mutation ratio for common SNPs (Supplementary Note) 20 . To identify purifying selection of loss-of-function variation, we tabulated counts of loss-of-function versus non-loss-of-function variation, stratified by frequency. We considered loss-of-function SNVs versus synonymous SNVs, loss-of-function indels versus non-frameshift indels and loss-of-function structural variants versus structural variants only removing intronic regions (Supplementary Fig. 2 ).
Compound heterozygote loss-of-function events were extracted and stratified by frequency (Supplementary Table 3) . Residual variation intolerance scores (RVIS) 24 were extracted for genes with loss-of-function variants in GoNL (Supplementary Table 3 ).
De novo mutation analyses. De novo mutations were called using GATK PhaseByTransmission and filtered using a random forest machine learning algorithm (Supplementary Note). We fit both a linear model and a log-linear model (assuming a Poisson distribution of the residuals) to the number of de novo mutations in the offspring given the father's age at conception, conditioning on the depth of coverage of each trio. We also tested the effect of the father's age on the number of de novo mutations in the offspring, conditioning on mother's age at conception. Using read-phase information, parent of origin was determined using GATK ReadBackedPhasing, and analyses were repeated on the paternal and maternal de novo mutations separately ( Supplementary  Fig. 5 and Supplementary Note).
Integrated phased panel construction. SNV genotype likelihoods (PLs) from the GATK UnifiedGenotyper were used as input for BEAGLE 69 , treating all samples as unrelated to produce a first set of haplotypes. A subset of SNPs (based on the Omni2.5M array) was extracted from the BEAGLE output to construct a phased scaffold using SHAPEIT2 (ref. 70 ) with trio information. This scaffold was used by MVNcall 19 to phase the remaining SNVs. For chromosome X, we truncated the male PLs in non-pseudoautosomal regions, yielding a negligible heterozygous genotype likelihood.
SNP discovery power and genotype concordance. SNP discovery power was estimated by comparing called sites with SNPs genotyped on the Immunochip (Supplementary Fig. 19 and Supplementary Note). Genotype concordance Imputation in Dutch samples. To evaluate imputation accuracy in Dutch samples, we used a set of 81 Dutch samples sequenced at ~40× coverage using Complete Genomics data from the population-based amyotrophic lateral sclerosis (ALS) study in the Netherlands (PAN) 72 . We used Complete Genomics genotypes at sites overlapping with Illumina Human-1M, 1000 Genomes Project and GoNL (702,253 SNPs) in these samples to impute the other Complete Genomics genotypes using IMPUTE2 (refs. 32,73) with 5 imputation panels: (i) GoNL, (ii) GoNL and 1000 Genomes Project, (iii) GoNL and 1000 Genomes Project EUR, (iv) 1000 Genomes Project and (v) 1000 Genomes Project EUR. Imputation accuracy was measured using the aggregate Pearson's r 2 correlation between the Complete Genomics genotypes and the imputed dosages (Fig. 3 and Supplementary Note).
Imputation with country-specific reference panels. We created 3 countryspecific imputation panels of equal size (n = 85) using the TSI and CEU samples from the 1000 Genomes Project and GoNL samples. Using the different panels, we imputed into non-overlapping samples sequenced with Complete Genomics (n = 1 for TSI; n = 3 for CEU; n = 5 for NTL) ( Supplementary Fig. 7 and Supplementary Note).
Comparison of imputation accuracy using different chips. Using NTL samples, we evaluated GoNL imputation accuracy for five different chips (Illumina-Human1M, HumanExomeCore, HumanOmniExpress, Affymetrix 500k and Affymetrix 6.0) by masking and imputing all variants not on the chip (Supplementary Fig. 6 and Supplementary Note).
Principal-components analysis. We performed 3 sets of PCA using EIGENSTRAT 74 (i) across GoNL and all 14 populations of the 1000 Genomes Project, (ii) GoNL and the 1000 Genomes Project EUR panel, and (iii) GoNL only (Supplementary Fig. 8 ). We computed PCA in scenario (i) for SNPs included on the Omni2.5M chip and with frequency of >5% in each individual population. We removed SNPs with missingness of >0.1% and pruned by linkage disequilibrium the remaining SNPs (r 2 < 0.3). We computed PCA in scenario (ii) following the same procedure except that we extracted sites included on the Omni1M chip. PCA in scenario (iii) (Fig. 4b) was computed using SNPs in phased haplotypes with a frequency of >10%, no missingness and pruned for linkage disequilibrium (r 2 < 0.3). Principal components were calculated in unrelated individuals only, and offspring were projected onto these principal components. We checked for principal-component significance (Tracy-Widom) and for spousal correlation along the top ten principal components (Supplementary Fig. 20, Supplementary Table 14 and Supplementary Note).
IBD-based demographic inference. We used phased SNPs (MAF >1%, phasing posterior = 1.0) and kept regions >45 cM in length (Supplementary Table 15 ) with IBD sharing within 5 s.d. of the mean. IBD sharing was inferred using GERMLINE and FastIBD 41, 75 . Ancestral population sizes were inferred using the average fraction f of the genome spanned by segments of 1-2 cM in length for a pair of individuals. Recent effective size was inferred using segments >7 cM in length through the estimator ˆ/ ( ) N f f uf = − + − ( ) 50 1 1 , where µ represents the minimum length in cM 76 . The average time to a common ancestor was estimated using DoRIS 76 . Populations were grouped into northern, central and southern using hierarchical clustering 77 on the basis of sharing of IBD segments >1 cM in length. Demographic models involving a single or multiple populations with migration were analyzed using DoRIS 76, 78 .
Runs of homozygosity. We used PLINK 79 to find runs of homozygous genotypes (SNPs with MAF of >5% and run length of >500 kb with at most one heterozygote genotype) using sliding windows of 5 Mb in unrelated GoNL and 1000 Genomes Project samples (Supplementary Fig. 21 ). We performed analysis of variance (ANOVA) to compare means between Dutch regions (northern, central and southern) on the basis of 1,000 bootstrap samples (Supplementary Note).
Population differentiation (F ST ). We computed Hudson's F ST and Weir and Cockerham's (WC) F ST between GoNL and each 1000 Genomes Project population. For the WC estimate, we calculated F ST from allele frequency data using correction for small sample size 80 . We calculated Hudson's F ST estimate on two different sets of SNPs, using (i) the 1000 Genomes Project YRI (Yoruba in Ibadan, Nigeria) population as an 'outgroup' population and (ii) sites polymorphic in the YRI population and in both populations for which the F ST was calculated (Supplementary Table 5 and Supplementary Note). We also computed Hudson's F ST between (i) the 11 Dutch provinces in GoNL and (ii) between the 3 regions (northern, central and southern) used in the IBD and f 2 analyses (Supplementary Table 16 and Supplementary Note).
Rare variant f 2 sharing analysis. We performed an interpopulation f 2 analysis by merging 1000 Genomes Project data and 88 random samples from GoNL (matching 1000 Genomes Project European population size) evenly distributed among the 11 provinces (Supplementary Fig. 9 and Supplementary Note). We performed f 2 analysis using 330 GoNL samples selected evenly across the 11 provinces (Fig. 4) . Provinces were then grouped into three regions (northern, central and southern), and proportions of f 2 sharing between provinces and regions were tested using a chi-squared test (Supplementary Note).
Singleton analysis. A filtered set of singletons was extracted from the SNPs. To account for sequencing biases, we computed the residuals of the following generalized linear regression (GLM) model: singletons per individual ~sequencing batch + biobank + depth of coverage + transmitted singletons. To investigate for possible geographic differences in genic singletons, we computed the Pearson's correlation between the principal components and (i) the singleton counts and (ii) the residuals of the GLM (Supplementary Fig. 22 ).
Impact of indels and structural variants. We used 1,000 permutations to compute differences in the distribution of indels and structural variants with respect to intergenic, intronic, exonic, OMIM and loss-of-function annotations (Supplementary Table 17 ).
